07/07/2023
$950,000!!!
What a historic day, we’ve raised $50,000 in the last 36 hours and at the same time our fundraising is hard at work as the FDA granted traditional approval of lecanemab, sold under the brand name Leqembi, for the treatment of early-stage Alzheimer’s disease.
“While this is a tremendous step forward, the Alzheimer’s Association's work is far from done. We won’t rest until everyone living with Alzheimer’s — at any stage — can get the treatment, care and support they need and deserve.” Dr. Joanne Pike
Read more — https://www.alz.org/news/2023/lecanemab-leqembi-traditional-fda-approval-full